Sun, Sep 21, 2014, 11:13 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Response Genetics, Inc Message Board

  • paradise.1933 paradise.1933 Apr 11, 2010 5:13 AM Flag

    Here's RGDX's March Highlights

    - RGDX receives notice of delisting from NASDAQ.
    - RGDX files a NT 10-K because they can't timely file.
    - An investor files a SEC document to try and overthrow the Board and Management.
    - RGDX does another private placement....$4M this time and further dilutes their shareholders. And this is part of the reason why they want to overthrow the board...all this dilution.

    Gee....I don't know Bagger...not exactly a stellar report card for RGDX...but hey Franck tells you it's all good...so it must be good...right Bagger.

    So if Franck told you to jump off a cliff...would you do it....how pathetic.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Million!!, because this is fastest way to get info about gene!!!

      • 2 Replies to bradley_copp
      • actually I do not think RGDX is focused on this potentially lucrative hospital business as much as they are focused on individual oncology practices. Thats the low hanging fruit and there are million$ of dollars of easy business to be had in the docs office! When you win over a large private practice and deliver the results the doc needs,your repeat business is strong. I believe RGDX reports about 75% of offices reorder! Thats good initial targeting and focused marketing. As they grow from 15 sales reps to say 30 or 50 they may be able to cherry pick the local hospital where the top 5 oncologists that are already on board can effect a hospital lab change for RGDX!

        Personally I think they are bought out in 1 year or so once we see BOD changes which are inevitable now that we have a proxy and June meeting scheduled!

        This company can easily do 13M in pp sales this year another 5M in pharma contracts so I give them 18M in sales. That is just 10% straight line growth!

        Someone like a Quiagen could scoop up this business easily for 4-5 times current market cap which would be in the 9.40-11.75 range per share!

        I think if we see a BOD change that includes Millman than ROCHE will be likely acquirer!

        This industry is so fragmented now w/ so many players that someone will start the buying spree soon and we see consolidation quickly! there are too many economy of scale dollars to be made by efficiencies only larger players can bring to the table.

        Our task is to find those cos. attractive enough to be bought and RGDX is one of them, of course that is contingent on some changes, IMO that is coming and katherine-ceo probably wants to see the changes, as long as she can retain her power and influence!

        frank

      • And let's see...who is going to win those hospital contracts...a little cash strapped Company on the verge of failure or the likes of a billion dollar company such as a QGEN.

        You people are clearly not thinking straight.

 
RGDX
0.78+0.04(+5.42%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.